Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphatidylcholine in pregnancy for child development
NCT03028857Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2017
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of phosphatidylcholine in neurodevelopmental disorder (NDD), sponsored by University of Colorado Denver. Primary endpoint: Child Behavior Checklist at 4 years. Started Jun 2017; status: completed.
02
Drugs
phosphatidylcholine
03
Conditions
neurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on NCT03028857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028857.